NCT04466683 Low-Dose Radiotherapy For Patients With SARS-COV-2 (COVID-19) Pneumonia Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT04466644 COVID-19: A Prevalence Study of Two ART Centres After the Pandemic Lockdown in the USA (COVID-19 Free Clinics) Status COMPLETED Phase N/A
NCT04466540 Randomized Placebo-controlled Trial of Hydroxychloroquine in Outpatient Cases With Coronavirus Disease 2019 (COVID-19) Status COMPLETED Phase PHASE4
NCT04466280 Efficacy and Safety of Mucoadhesive Sustained Release, Mucodentol, in Comparison With Hydroxychloroquine to Prevent COVID-19 Status WITHDRAWN Phase NA
NCT04466241 Combination Therapies to Reduce Carriage of SARS-Cov-2 and Improve Outcome of COVID-19 in Ivory Coast: a Phase Randomized IIb Trial Status COMPLETED Phase PHASE2/PHASE3
NCT04465981 Investigation of Antibody and Immune Responses to SARS-CoV-2 Proteins in COVID-19 Patients Status UNKNOWN Phase N/A
NCT04465695 Dual Therapy With Interferon Beta-1b and Clofazimine for COVID-19 Status UNKNOWN Phase PHASE2
NCT04465513 Investigation of the Efficacy of CARDIO Softgels PLUS Best-standard-of-care in the Recovery of Patients With COVID-19 Status COMPLETED Phase NA
NCT04465474 Coronavirus Disease 2019 (COVID-19) During Pregnancy: Prevalence of Seroconversion, Effect on Maternal and Perinatal Outcomes and Risk of Vertical Transmission (COVID-MAP) Status RECRUITING Phase N/A
NCT04464395 Study of CPI-006 as Immunotherapy for Hospitalized COVID-19 Patients Status COMPLETED Phase PHASE1
NCT04463420 Safety and Efficacy of PHR 160 Spray on the Outcomes of Patients With COVID-19 Status UNKNOWN Phase NA
NCT04463264 Efficacy and Safety Study of Nitazoxanide (NTX) in the Treatment of Patients With SARS-CoV-2 Virus Infection (COVID-19) Status UNKNOWN Phase PHASE2/PHASE3
NCT04463004 Mavrilimumab to Reduce Progression of Acute Respiratory Failure in COVID-19 Pneumonia and Systemic Hyper-inflammation Status COMPLETED Phase PHASE2